Cargando…
Pathophysiology and treatment of patients with beta-thalassemia – an update
Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of α-globin chains (α-thal) or β-globin chains (β-thal) that compose the major adult hemoglobin (α (2)β (2).) It is caused by one or more mutations in the corre...
Autores principales: | Fibach, Eitan, Rachmilewitz, Eliezer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749127/ https://www.ncbi.nlm.nih.gov/pubmed/29333256 http://dx.doi.org/10.12688/f1000research.12688.1 |
Ejemplares similares
-
Erythropoiesis In Vitro—A Research and Therapeutic Tool in Thalassemia
por: Fibach, Eitan
Publicado: (2019) -
The Price of Mercy: Comment to the Paper Entitled “Prevention of Beta Thalassemia In Northern Israel - A Cost-Benefit Analysis” by Koren et Al. recently published in Mediterranean Journal of Hematology and Infectious Diseases
por: Giordano, Piero C., et al.
Publicado: (2014) -
Gene Therapy For Beta-Thalassemia: Updated Perspectives
por: Karponi, Garyfalia, et al.
Publicado: (2019) -
Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018) -
Beta-thalassemia
por: Galanello, Renzo, et al.
Publicado: (2010)